Iris Medicine
PrivateLast Round
Grant
Sep 25, 2025
Total Funding Raised
$3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Iris Medicine operates in Healthcare & Life Sciences and is based in Berkeley, California. Its latest recorded funding round was a Grant round in September 2025.
Iris Medicine is a biotechnology company that develops a ribonucleic acid therapeutics platform designed to treat genetic diseases using small binding RNA (sbRNA) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iris Medicine Comparables
Compare Iris Medicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aptadir Therapeutics | 83% | |
| Switch Therapeutics | 83% | |
| Vico Therapeutics | 76% |
For institutional investors. Book with your work email.
Iris Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 25, 2025 | ||||
| Seed | May 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Iris Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCB Ventures | Seed |
| Pandect Catalyst Fund | Seed |
| Dolby Family Ventures | Seed |
| Altitude Life Science Ventures | Seed |
| UCB Ventures | Seed |
| California Institute for Regenerative Medicine | Grant |
| Venrock | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 43% MoM.
- Jul 25, 2026
Monthly visitors increased 60% MoM, reaching 1.3K.
For institutional investors. Book with your work email.
Iris Medicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Iris Medicine's valuation, stock price, and market status.
Is Iris Medicine a public or private company?
Iris Medicine is a private company.
What is the current stock price of Iris Medicine?
Iris Medicine is a private company, so its shares have no public market price. Caplight tracks Iris Medicine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Iris Medicine worth (valuation)?
Valuation information for Iris Medicine is not publicly available.
Can I buy Iris Medicine stock?
Iris Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Iris Medicine's last funding round?
Iris Medicine's most recent funding round was Grant on September 25, 2025.
Who are the main investors in Iris Medicine?
Key investors in Iris Medicine include California Institute for Regenerative Medicine, Venrock.
Will Iris Medicine IPO soon?
No public IPO plans have been announced for Iris Medicine.
How can I track Iris Medicine secondary market activity?
Caplight tracks bids, offers, and trades in Iris Medicine's shares on secondary markets.